Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Journey Medical (DERM) Revenue (2020 - 2025)

Historic Revenue for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $17.6 million.

  • Journey Medical's Revenue rose 2052.09% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.4 million, marking a year-over-year increase of 281.8%. This contributed to the annual value of $56.1 million for FY2024, which is 2910.67% down from last year.
  • Latest data reveals that Journey Medical reported Revenue of $17.6 million as of Q3 2025, which was up 2052.09% from $15.0 million recorded in Q2 2025.
  • Journey Medical's Revenue's 5-year high stood at $34.5 million during Q3 2023, with a 5-year trough of $10.7 million in Q1 2021.
  • Moreover, its 5-year median value for Revenue was $15.3 million (2021), whereas its average is $16.7 million.
  • In the last 5 years, Journey Medical's Revenue soared by 11733.37% in 2022 and then crashed by 5764.5% in 2024.
  • Journey Medical's Revenue (Quarter) stood at $17.5 million in 2021, then fell by 8.85% to $16.0 million in 2022, then fell by 4.44% to $15.3 million in 2023, then decreased by 10.73% to $13.6 million in 2024, then rose by 29.45% to $17.6 million in 2025.
  • Its Revenue was $17.6 million in Q3 2025, compared to $15.0 million in Q2 2025 and $13.1 million in Q1 2025.